AIM at Melanoma - Reshaping the Future Together

Reshaping
the Future Together

Finding the CURE is Personal

Transforming How Clinical Breakthroughs are Achieved

Our global initiatives change the face and the future of melanoma research.

Promoting Change, Locally and Globally

We represent the voice of those affected by melanoma in the US and foster the growth of new advocacy efforts throughout other countries.

View Our Global Efforts »

Reshaping the Future Together

Walking for the CURE

Join our Cause »

Groundbreaking

Research

Working Group

Tissue Bank

Education & Support

Stages of Melanoma

Stage 4

Reshaping the Future Together

Fundraising

AIM Walks & Fun Runs

Donate

AIM Fundraisers & Partner Programs

Sponsor Events

Speak with our Oncology Nurse

AIM offers their Nurse-on-Call Service free of charge to patients & caregivers.

Email Barbara

or call 1-877-246-2635

Search for a Melanoma Specialist

Clinical Trials Matching Service

See Details

Melanoma Education

From risk factors, to melanoma stages, to treatment, and beyond

Learn More »

Innovative Research

Changing the face and future of melanoma research to discover the CURE

Learn More »

Global Engagement & Advocacy

Most influential voice in melanoma, locally and globally

Learn More »

Leading the Way in Legislation

Leading and winning legislative and regulatory change across the country

Learn More »

Melanoma News & Events

News 03/03/2015

U.S. FDA Wants More Data on Sunscreen Additives Before Approval

News 03/02/2015

The FDA Accepts Supplemental Biologics License Application for Yervoy® (ipilimumab) as Adjuvant Treatment for Patients with Stage 3 Melanoma Who Are at High Risk of Recurrence

News 02/19/2015

FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma

News 12/22/2014

FDA Approves Opdivo for Advanced Melanoma

News 12/16/2014

Novogen Announces Breakthrough Discovery in the Treatment of Melanoma

News 11/19/2014

Skin Cancer Risks: Outdoor Work Contributes To High Melanoma Death Rate For Men Over 45

News 11/18/2014

Treatments Show Promise In Metastatic Melanoma

News 11/16/2014

Study Comparing Opdivo (nivolumab) to Chemotherapy in Treatment Naïve Advanced Melanoma Patients Marks First PD-1 Immune Checkpoint Inhibitor to Demonstrate a Survival Benefit in a Phase 3 Trial

News 11/10/2014

Skin Cancer Treatment Costs on the Rise

News 11/05/2014

Common Myths About Skin Cancer Debunked

News 11/05/2014

Reshaping
the Future Together

Transforming How Clinical Breakthroughs are Achieved

Promoting Change, Locally and Globally

Reshaping the Future Together

Research

Stages of Melanoma

Fundraising

Speak with our Oncology Nurse

Search for a Melanoma Specialist

Clinical Trials Matching Service

Melanoma Education

Innovative Research

Global Engagement & Advocacy

Leading the Way in Legislation

Melanoma News & Events

U.S. FDA Wants More Data on Sunscreen Additives Before Approval

The FDA Accepts Supplemental Biologics License Application for Yervoy® (ipilimumab) as Adjuvant Treatment for Patients with Stage 3 Melanoma Who Are at High Risk of Recurrence

FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma

FDA Approves Opdivo for Advanced Melanoma

Novogen Announces Breakthrough Discovery in the Treatment of Melanoma

Skin Cancer Risks: Outdoor Work Contributes To High Melanoma Death Rate For Men Over 45

Treatments Show Promise In Metastatic Melanoma

Study Comparing Opdivo (nivolumab) to Chemotherapy in Treatment Naïve Advanced Melanoma Patients Marks First PD-1 Immune Checkpoint Inhibitor to Demonstrate a Survival Benefit in a Phase 3 Trial

Skin Cancer Treatment Costs on the Rise

Common Myths About Skin Cancer Debunked

Promising New Cancer Treatment Uses Immune Cells

Please keep me informed.